Detalhe da pesquisa
1.
Oncology pharmacy practice in the United States: Results of a comprehensive, nationwide survey.
J Oncol Pharm Pract
; 30(2): 332-341, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194276
2.
The clinical and financial impact of remote clinical oncology pharmacist engagement in community-based practices within The US Oncology Network.
J Oncol Pharm Pract
; 30(1): 165-172, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37151016
3.
Rasburicase dose optimization for tumor lysis syndrome management in a network of community oncology practices.
J Oncol Pharm Pract
; : 10781552231190005, 2023 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37563922
4.
Expanding oncology pharmacist teams: Justifying the return on investment.
J Oncol Pharm Pract
; 28(6): 1381-1387, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35274995
5.
Implementation and outcomes of a pharmacist-led collaborative drug therapy management program for oncology symptom management.
Support Care Cancer
; 29(11): 6505-6510, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-33905012
6.
Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team.
J Oncol Pharm Pract
; 27(1): 5-13, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32237957
7.
Real-world comparison of immune checkpoint inhibitors in non-small cell lung cancer following platinum-based chemotherapy.
J Oncol Pharm Pract
; 26(3): 564-571, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31238808
8.
Rational use of rasburicase for the treatment and management of tumor lysis syndrome.
J Oncol Pharm Pract
; 24(3): 176-184, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077046
9.
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(12): 1520-1541, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29223990
10.
Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.
Support Care Cancer
; 23(8): 2287-95, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25576429
11.
Financial Impact of an Automated Oncology Dose-Rounding Initiative: One-Year Analysis.
JCO Clin Cancer Inform
; 5: 805-810, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34351786
12.
Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting.
JCO Oncol Pract
; 17(9): e1303-e1310, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534634
13.
Clinician Report of Oral Oncolytic Symptoms and Adherence Obtained via a Patient-Reported Outcome Measure (PROM).
JCO Clin Cancer Inform
; 3: 1-6, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31100014
14.
Oncology Pharmacist Opportunities: Closing the Gap in Quality Care.
J Oncol Pract
; 14(6): e403-e411, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29298114
15.
Implementing a Method for Evaluating Patient-Reported Outcomes Associated With Oral Oncolytic Therapy.
J Oncol Pract
; 13(4): e395-e400, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28195813
16.
Clinical developments in the treatment of relapsed or relapsed and refractory multiple myeloma: impact of panobinostat, the first-in-class histone deacetylase inhibitor.
Onco Targets Ther
; 9: 2783-93, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274274